Reaction

Labyrinthitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,517 reports · 45 co-occurring drugs

As of the last recalculation, Labyrinthitis appears in 2,517 FAERS reports alongside 45 co-occurring drug terms. The strongest observed disproportionality signal is VALSARTAN AND HYDROCHLOROTHIAZIDE (PRR 18.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Valsartan And Hydrochlorothiazide	30	18.5	18.5
Octreotide Acetate	65	18.0	18.0
Desoximetasone	40	17.6	17.7
Dimenhydrinate	20	15.6	15.7
Cetiirizine	61	12.2	12.2
Antacid	68	12.1	12.2
Captopril	13	11.2	11.2
Dutasteride	11	11.2	11.2
Ciclesonide	18	11.0	11.0
Alendronate Sodium	128	11.0	11.0
Meclizine Hydrochloride	23	9.8	9.8
Calcium Carbonate	74	9.4	9.4
Meclizine	17	8.7	8.7
Cetirizine	77	8.4	8.4
Ezetimibe And Simvastatin	15	8.2	8.2
Meclizine Hcl 12.5Mg	13	7.9	7.9
Meclizine Hcl 25Mg	13	7.9	7.9
Meclizine Hcl 12.5 Mg	13	7.9	7.9
Meclizine Hcl 25 Mg	13	7.9	7.9
Methimazole	7	7.4	7.4
Fluoxetine	58	7.3	7.3
Citalopram Hydrobromide	89	7.1	7.1
Indapamide	15	7.0	7.0
Hydroxyzine Hydrochloride	10	6.3	6.3
Hydroxyzine Hydrochloride Oral	10	6.3	6.3
Ramipril	91	6.3	6.3
Citalopram	100	6.3	6.3
Mirtazapine	67	6.2	6.2
Rivastigmine	14	6.2	6.2
Cholestyramine	9	6.2	6.2
Clopidogrel Bisulfate	72	6.0	6.0
Infliximab-Dyyb	20	5.7	5.7
Omalizumab	56	5.5	5.5
Interferon Beta-1A	118	5.2	5.3
Cladribine	6	5.2	5.2
Latanoprost	26	4.3	4.3
Lanreotide Acetate	4	4.2	4.2
Travoprost	4	3.8	3.8
Brinzolamide	4	3.8	3.8
Golimumab	36	3.5	3.5
Prasugrel Hydrochloride	4	3.3	3.3
Conjugated Estrogens And Medroxyprogesterone Acetate	7	2.5	2.5
Orlistat	7	2.2	2.2
Tafamidis	3	2.1	2.1
Droxidopa	3	1.1	1.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.